메뉴 건너뛰기




Volumn 60, Issue 21, 2000, Pages 6089-6094

Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin θ(I) 1

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CALICHEAMICIN DERIVATIVE; CALICHEAMICIN THETA1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 138H11; MONOCLONAL ANTIBODY CH14.18; TECHNETIUM 99M; UNCLASSIFIED DRUG;

EID: 0034326838     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (23)

References (29)
  • 2
    • 0033074437 scopus 로고    scopus 로고
    • Renal cell carcinoma: Management of advanced disease
    • (1999) J. Urol. , vol.161 , pp. 381-386
    • Figlin, R.A.1
  • 5
    • 0024310179 scopus 로고
    • Failure of cytotoxic chemotherapy, 1983-1988, and the emerging role of monoclonal antibodies for renal cancer
    • (1989) Urol. Int. , vol.44 , pp. 338-345
    • Yagoda, A.1    Bander, N.H.2
  • 9
    • 0032580508 scopus 로고    scopus 로고
    • Metastatic renal-cell carcinoma: What causes occasional dramatic regressions?
    • (1998) N. Engl. J. Med. , vol.338 , pp. 1305-1306
    • Young, R.C.1
  • 16
    • 0029858287 scopus 로고    scopus 로고
    • Hybridomas reveal shared immunodominant epitopes of γ-glutamyltransferase isoforms from human kidney and renal cell carcinoma
    • (1996) Tumor Biol. , vol.17 , pp. 369-377
    • Fischer, P.1    Scherberich, J.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.